Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ISIS 3521: Phase I/II

Additional data from ISIP's ongoing Phase I/II trial of ISIS 3521 in combination with carboplatin and

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE